A
Adriana Campi
Researcher at University of Milan
Publications - 50
Citations - 3872
Adriana Campi is an academic researcher from University of Milan. The author has contributed to research in topics: Multiple sclerosis & Lesion. The author has an hindex of 29, co-authored 50 publications receiving 3780 citations. Previous affiliations of Adriana Campi include Università telematica San Raffaele & Vita-Salute San Raffaele University.
Papers
More filters
Journal ArticleDOI
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.
Frederik Barkhof,Massimo Filippi,David Miller,Philip Scheltens,Adriana Campi,Chris H. Polman,Giancarlo Comi,Herman J. Adèr,N. A. Losseff,Jacob Valk +9 more
TL;DR: It is concluded that a four-parameter dichotomized MRI model including gadolinium-enhancement, juxtacortical, infratentorial and periventricular lesions best predicts conversion to clinically definite multiple sclerosis.
Journal ArticleDOI
A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis
Massimo Filippi,Adriana Campi,Vincent Dousset,C. Baratti,Vittorio Martinelli,Nicola Canal,Giuseppe Scotti,G. Comi +7 more
TL;DR: It is confirmed that there are alterations in the NAWM of MS patients and it is suggested that such changes might be relevant to the disability in MS.
Journal ArticleDOI
Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery
Massimo Filippi,Tarek A. Yousry,C Baratti,Mark A. Horsfield,S Mammi,Christoph R. Becker,Raymond Voltz,Simone Spuler,Adriana Campi,Maximilian F. Reiser,G. Comi +10 more
TL;DR: The data indicate that fast-FLAIR sequences are more sensitive than CSE in detecting multiple sclerosis lesion burden and that fast, fluid-attenuated inversion recovery is a promising technique for natural history studies and clinical trials in multiple sclerosis.
Journal ArticleDOI
Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images.
Marco Rovaris,Massimo Filippi,Giliola Calori,M. Rodegher,Adriana Campi,Bruno Colombo,Giancarlo Comi +6 more
TL;DR: The findings suggest that non-conventional MR techniques may be reliable outcome measures for clinical trials in MS.
Journal ArticleDOI
Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.
Massimo Filippi,Tarek A. Yousry,Adriana Campi,C Kandziora,Bruno Colombo,Raymond Voltz,Vittorio Martinelli,Simone Spuler,S. Bressi,Giuseppe Scotti,G. Comi +10 more
TL;DR: The data indicate that in patients with MS, a triple dose of gadolinium-DTPA can reveal many more enhancing lesions, which also appear larger, which suggests that the pathologic nature of ``active'' lesions in MS is heterogeneous, which might have impact on planning clinical trials.